{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:30:32Z","timestamp":1772641832416,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.leukres.2009.09.025","type":"journal-article","created":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T08:17:41Z","timestamp":1255594661000},"page":"e94-e96","source":"Crossref","is-referenced-by-count":11,"title":["A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2V617F myeloproliferative neoplasm"],"prefix":"10.1016","volume":"34","author":[{"given":"L.","family":"V\u00e9ron\u00e8se","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tchirkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Richard-Pebrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ledoux-Pilon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chaleteix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Goumy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gouas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.O.","family":"Bay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Tournilhac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.09.025_bib1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signaling causes polycythemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2009.09.025_bib2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2009.09.025_bib3","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.09.025_bib4","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood-2005-05-1800","article-title":"JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia","volume":"106","author":"Jelinek","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.09.025_bib5","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.leukres.2008.03.011","article-title":"JAK2-V617F and BCR-ABL\u2014double Jeopardy?","volume":"32","author":"Kr\u00e4mer","year":"2008","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2009.09.025_bib6","first-page":"993","article-title":"Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis","volume":"6","author":"Bornh\u00e4user","year":"2008","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2009.09.025_bib7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1470-2045(07)70295-4","article-title":"Insights into JAK2-V617F mutation in CML","volume":"8","author":"Bocchia","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.leukres.2009.09.025_bib8","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.leukres.2008.03.004","article-title":"Emergence of therapy-unrelated CML on a background of BCR-ABL-negative JAK2V617F-positive chronic idiopathic myelofibrosis","volume":"32","author":"Jallades","year":"2008","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2009.09.025_bib9","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.5858\/2007-131-1719-TOPVTC","article-title":"Transformation of polycythemia vera to chronic myelogenous leukemia","volume":"131","author":"Mirza","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.leukres.2009.09.025_bib10","article-title":"BCR-ABL positive chronic myeloid leukemia with concurrent JAK2(V617F) positive myelodysplastic syndrome\/myeloproliferative neoplasm (RARS-T)","author":"Gattenlohner","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2009.09.025_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12185-008-0131-2","article-title":"Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia","volume":"88","author":"Conchon","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.leukres.2009.09.025_bib12","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/sj.leu.2405088","article-title":"JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders","volume":"22","author":"Cambier","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.09.025_bib13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.leu.2404591","article-title":"Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemia","volume":"21","author":"Inami","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.09.025_bib14","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2006-12-061135","article-title":"Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation","volume":"109","author":"Hussein","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.09.025_bib15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S1470-2045(07)70206-1","article-title":"JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukemia","volume":"8","author":"Kr\u00e4mer","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.leukres.2009.09.025_bib16","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2006-01-013540","article-title":"The JAK2V617F mutation is frequently present at diagnosis in patients with essential thrombocytemia and polycythemia vera","volume":"108","author":"Lippert","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.09.025_bib17","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood-2005-11-009605","article-title":"Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders","volume":"108","author":"Kralovics","year":"2006","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609004858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609004858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T09:40:19Z","timestamp":1634031619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609004858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0145212609004858"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.09.025","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}